About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker BEAM

Latest patent grants
GrantedPatentOwnerTypeSource
Oct 20, 202612767959
Nucleobase editors having reduced off-target deamination and methods…
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Oct 13, 202612760286
Methods of editing nucleotide polymorphism using programmable base ed…
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Oct 6, 202612753147
Nanomaterials comprising acetals
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
May 12, 202612622931
Compositions and methods for treating alpha-1 antitrypsin deficiency
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Apr 28, 202612612618
Nucleobase editors having reduced non-target deamination and assays f…
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Apr 14, 202612600971
Modified immune cells having adenosine deaminase base editors for mod…
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Apr 7, 202612594301
Compositions and methods for treatment of liquid cancers
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Mar 17, 202612576151
Fratricide resistant modified immune cells and methods of using the s…
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Jan 20, 202612529041
Compositions and methods for delivering a nucleobase editing system
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Oct 28, 202512454694
Compositions and methods for improving base editing
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
May 13, 202512296053
Nanomaterials comprising triols
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Apr 8, 202512268753
Nanomaterials comprising a biodegradable feature
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Nov 5, 202412133884
Methods of substituting pathogenic amino acids using programmable bas…
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗
Oct 22, 202412125145
Systems and methods for implemented mixed reality in laboratory autom…
BEAM
Beam Therapeutics Inc.
utilityGoogle Patents ↗

14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:50 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances